£96.81

It has never been this cheap. We have no record of a lower price.

£97 today · cheaper than every other day in the last 3 months

Springer Neuroendocrine Neoplasia Management: New Approaches for Diagnosis and Treatment

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 60 days · 60 data points (no recent data)

Historical
Generating forecast…
£96.91 £96.80 £96.82 £96.85 £96.87 £96.90 £96.92 27 July 2026 10 August 2026 25 August 2026 09 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 31 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 60 days • 1 price levels

Days at Price
60 days 0 15 30 45 60 £97 Days at Price

Price Analysis

Most common price: £97 (60 days, 100.0%)

Price range: £97 - £97

Price levels: 1 different prices over 60 days

Description

This book provides the most recent update on the management of neuroendocrine neoplasia (NEN), a term covering all tumors of various organs and/or with a particular histology, including MEN (multiple endocrine neoplasia) related tumors, MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasms), NEC (neuroendocrine carcinoma) and Merkel’s carcinoma. NENs are heterogeneous in their biology, clinical presentation and prognosis, showing a great variability in aggressiveness and therapy response. As a result, their treatment is based on a large spectrum of options. The standard therapies are surgery in early disease, various loco-regional procedures in certain conditions and mostly of a palliative nature in metastatic disease. At present, thanks to our increased understanding of molecular signaling pathways, several pharmacological approaches can be used in patients with advanced NENs. Somatostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptortreatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging results in advanced disease. The first part of the book focuses on the history, epidemiology and the most relevant scientific achievements, covering the discoveries in genetic and molecular biology, the endoscopic techniques with guided biopsy, and the metabolic imaging with hybrid PET/CT and MRI/CT. It particularly highlights the emerging strategies in therapy, surgery and mini-invasive surgery as well as loco-regional and systemic treatments, including targeted therapy and/or biological therapies. The second part then explores the management of NENs of various anatomical origins and/or with peculiar biology. It describes the range of the current options and the most relevant results from the clinical trials. This informative book provides valuable insights for all thoseinterested in the management of neuroendocrine neoplasia.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
17 July 2021
Listed Since
25 February 2021

Barcode

No barcode data available

Similar Products You Might Like

The Spectrum of Neuroendocrine Neoplasia: A Practical Approach to Diagnosis, Classification and Therapy
99% match

The Spectrum of Neuroendocrine Neoplasia: A Practical Approach to Diagnosis, Classification and Therapy

Springer

£81.74 11 Sep 2026
Neuroendocrine Tumours: Diagnosis and Management
98% match

Neuroendocrine Tumours: Diagnosis and Management

Springer

£140.10 02 Oct 2026
Neuroendocrine Tumors: Surgical Evaluation and Management
98% match

Neuroendocrine Tumors: Surgical Evaluation and Management

Springer

£73.14 25 Sep 2026
Endoscopic Treatment Strategy for Upper GI Tract Neoplasms
97% match

Endoscopic Treatment Strategy for Upper GI Tract Neoplasms

Springer

£71.08 23 Sep 2026
Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients
96% match

Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients

Springer

£95.71 03 Oct 2026
Neuroendocrine-Immune System Interactions: 13 (Masterclass in Neuroendocrinology, 13)
96% match

Neuroendocrine-Immune System Interactions: 13 (Masterclass in Neuroendocrinology, 13)

Springer

£141.08 12 Sep 2026
Hormone Related Cancer Mechanistic and Nanomedicines: Challenges and Prospects
96% match

Hormone Related Cancer Mechanistic and Nanomedicines: Challenges and Prospects

Springer

£104.53 23 Sep 2026
Diagnosis and Management of Endocrine-related Tumors: 20 (Cancer Treatment and Research, 20)
96% match

Diagnosis and Management of Endocrine-related Tumors: 20 (Cancer Treatment and Research, 20)

Springer

£146.53 09 Sep 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 02 Sep 2026
Neuroendocrine Neoplasms, An Issue of PET Clinics: Volume 18-2 (The Clinics: Radiology, Volume 18-2)
96% match

Neuroendocrine Neoplasms, An Issue of PET Clinics: Volume 18-2 (The Clinics: Radiology, Volume 18-2)

Elsevier

£53.22 18 Sep 2026
Skin Neoplasms: A Clinical and Pathological Approach
96% match

Skin Neoplasms: A Clinical and Pathological Approach

Foster Academics

£77.68 19 Sep 2026
Emerging Concepts in Neuro-Oncology
96% match

Emerging Concepts in Neuro-Oncology

Springer

£84.04 17 Sep 2026
New Nanomaterials and Techniques for Tumor-targeted Systems
96% match

New Nanomaterials and Techniques for Tumor-targeted Systems

Springer

£73.87 07 Sep 2026
New Nanomaterials and Techniques for Tumor-targeted Systems
96% match

New Nanomaterials and Techniques for Tumor-targeted Systems

Springer

£72.98 11 Sep 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India

£515.00 02 Sep 2026
Retroperitoneal Tumors: Clinical Management
96% match

Retroperitoneal Tumors: Clinical Management

Springer

£88.92 02 Oct 2026
Nanoengineered Therapeutics for Lung Cancer: Advanced Drug Delivery Strategies
96% match

Nanoengineered Therapeutics for Lung Cancer: Advanced Drug Delivery Strategies

Elsevier

£131.36 23 Sep 2026
Modern Nanomaterials and Nanotechnology for Cancer Therapy
96% match

Modern Nanomaterials and Nanotechnology for Cancer Therapy

Springer

£147.14 27 Aug 2026
Polyphenols-based Nanotherapeutics for Cancer Management
96% match

Polyphenols-based Nanotherapeutics for Cancer Management

Springer

£83.49 03 Oct 2026
Glial-Neuronal Signaling in Neuroendocrine Systems: 11 (Masterclass in Neuroendocrinology, 11)
96% match

Glial-Neuronal Signaling in Neuroendocrine Systems: 11 (Masterclass in Neuroendocrinology, 11)

Springer

£121.12 24 Sep 2026
Atlas of Thyroid and Neuroendocrine Tumor Markers
96% match

Atlas of Thyroid and Neuroendocrine Tumor Markers

Springer

£73.11 03 Oct 2026
Lymph Node Metastasis in Gastrointestinal Cancer
96% match

Lymph Node Metastasis in Gastrointestinal Cancer

Springer

£110.04 23 Sep 2026
Endocrine Surgery in Children
96% match

Endocrine Surgery in Children

Springer

£131.78 24 Sep 2026
Advanced Imaging and Therapy in Neuro-Oncology
96% match

Advanced Imaging and Therapy in Neuro-Oncology

Springer

£95.74 18 Sep 2026